Mycobacteriosis, which encompasses tuberculosis, leprae and nontuberculous mycobacteriosis, presents significant challenges ...
Thousands of women in England will now be able to access the morning after pill for free from pharmacies, as part of the ...
ScienceAlert on MSN
Powerful New Antibiotic Was 'Hiding in Plain Sight' For Decades
Researchers have just identified a powerful new antibiotic – in a significant discovery made not by breaking new ground, but ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...
Existing methods for antibiotic selection are based on outdated and inaccurate microbiological principles, causing millions of inappropriate antibiotic selections and hundreds of thousands of ...
A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It ...
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
Chemists from the university, along with a team from Monash University, Australia, said the compound, called ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...
MyChesCo on MSN
AstraZeneca and Amgen Secure FDA Approval for TEZSPIRE to Treat Chronic Rhinosinusitis with Nasal Polyps
AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results